Evaxion Biotech A/S
NASDAQ:EVAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Volkswagen AG
OTC:VLKPF
|
DE |
|
Union Bank of India Ltd
NSE:UNIONBANK
|
IN |
|
ARSS Infrastructure Projects Ltd
NSE:ARSSINFRA
|
IN |
|
Shanxi Huhua Group Co Ltd
SZSE:003002
|
CN |
|
Alpha and Omega Semiconductor Ltd
NASDAQ:AOSL
|
US |
|
Nanjing Sample Technology Co Ltd
HKEX:1708
|
CN |
|
Anheuser-Busch Inbev SA
XBRU:ABI
|
BE |
|
Hubei Energy Group Co Ltd
SZSE:000883
|
CN |
|
I
|
Intuitive Machines Inc
NASDAQ:LUNR
|
US |
Evaxion Biotech A/S
EPS (Diluted)
Evaxion Biotech A/S
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Evaxion Biotech A/S
NASDAQ:EVAX
|
EPS (Diluted)
$0
|
CAGR 3-Years
93%
|
CAGR 5-Years
78%
|
CAGR 10-Years
N/A
|
|
|
Genmab A/S
CSE:GMAB
|
EPS (Diluted)
kr15
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
23%
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
EPS (Diluted)
kr91
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Galecto Inc
NASDAQ:GLTO
|
EPS (Diluted)
-$18
|
CAGR 3-Years
-108%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
EPS (Diluted)
-€3
|
CAGR 3-Years
29%
|
CAGR 5-Years
15%
|
CAGR 10-Years
-10%
|
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
EPS (Diluted)
kr17
|
CAGR 3-Years
N/A
|
CAGR 5-Years
28%
|
CAGR 10-Years
27%
|
|
Evaxion Biotech A/S
Glance View
Evaxion Biotech A/S discovers and develops novel immunotherapies for cancer and infectious diseases. The firm decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.
See Also
What is Evaxion Biotech A/S's EPS (Diluted)?
EPS (Diluted)
-0
USD
Based on the financial report for Dec 31, 2025, Evaxion Biotech A/S's EPS (Diluted) amounts to -0 USD.
What is Evaxion Biotech A/S's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
78%
Over the last year, the EPS (Diluted) growth was 98%. The average annual EPS (Diluted) growth rates for Evaxion Biotech A/S have been 93% over the past three years , 78% over the past five years .
